"Over 800 students diagnosed with HIV in this state, with 47 fatalities documented: Complete report"

source - TOI

In Tripura, 828 students have tested positive for HIV

"In Tripura, 828 students have tested positive for HIV, with 47 fatalities and 572 currently alive. Intravenous drug use has affected 220 schools and 24 colleges. Information gathered from 164 health centers reveals that several students come from wealthy backgrounds, with some being migrants. The Joint Director of TSACS emphasizes the importance of harm reduction, counseling, testing, and addiction rehabilitation. Antiretroviral therapy remains essential for managing HIV."

"A concerning HIV report has deeply concerned everyone. According to the findings, 828 students in Tripura have been diagnosed as HIV-positive, with 47 fatalities recorded.

"Thus far, we have identified 828 students living with HIV. Among them, 572 are currently alive, while we have mourned the loss of 47 individuals due to this serious infection. A significant number of students have relocated from Tripura to pursue higher education in prestigious institutions across the country," stated a senior official from the Tripura State AIDS Control Society (TSACS)."

"Why is this happening? The Tripura AIDS Control Society has identified students in 220 schools and 24 colleges and universities who are using injectable drugs.

"Up to now, we have pinpointed 220 schools and 24 colleges and universities where students are addicted to intravenous drug use. We have gathered this information from a total of 164 health facilities statewide. We have obtained reports from nearly all the blocks and subdivisions before compiling this presentation," the Joint Director of TSACS told ANI."

"In many instances, children from well-to-do families have been diagnosed with HIV. There are households where both parents hold government positions and readily meet their children's demands. By the time they realize their children have fallen into drug addiction, it's often too late," he explained.

Needle sharing stands out as a primary method of HIV transmission. HIV/AIDS remains a significant global health challenge, closely linked to intravenous drug abuse. Sharing needles among drug users is a major route of HIV transmission, facilitating the virus's spread through blood contact. In numerous areas, such behavior contributes significantly to new HIV infections.

Factors contributing to this link include unsafe injection practices, limited access to clean needles, and the marginalization of drug-using communities. Sharing needles, syringes, or other injecting equipment dramatically increases the risk of HIV transmission, as the virus can survive in residual blood outside the body.

Efforts to address this issue include harm reduction strategies like needle exchange programs, providing sterile equipment to drug users to minimize infection risk. These initiatives also offer counseling, testing, and referrals to addiction treatment services, aiming to reduce HIV transmission while addressing substance use disorders.

However, challenges remain, including stigma against drug users, legal obstacles to harm reduction initiatives, and the complex social and economic environments in which drug abuse occurs. Addressing the intersection of HIV and intravenous drug use necessitates comprehensive approaches integrating public health, social services, and community engagement to mitigate risks and support affected individuals effectively.

Antiretroviral Therapy (ART) remains crucial in HIV management. "As of May 2024, our ART centers have registered 8,729 individuals. Among them, 5,674 are living with HIV, comprising 4,570 males, 1,103 females, and one transgender patient," an official stated.

Antiretroviral therapy (ART) is the cornerstone of HIV/AIDS treatment, combining medications that suppress viral replication in the body. By inhibiting viral activity, ART helps maintain low HIV levels in the bloodstream (viral load), preserving immune function and preventing AIDS progression. While ART does not cure HIV, it effectively controls the virus, enabling people living with HIV to lead longer and healthier lives. Adherence to ART is critical for its effectiveness, requiring daily medication as prescribed. Ongoing research aims to enhance ART regimens for better outcomes and reduced side effects.